November 15, 2017. By Lucy Campbell.
Philadelphia, PA: The makers of Risperdal, Janssen Pharmaceuticals and its parent company Johnson & Johnson (J&J) must face a retrial of a lawsuit alleging their anti-psychotic drug Risperdal caused the plaintiff, a young man referred to as WC, to grow female-like breasts.Read [ New Risperdal Trial Ordered ]
October 27, 2017. By Jane Mundy.
Syracuse, NY: A federal jury at the beginning of October found that Johnson & Johnson and Janssen, the Risperdal manufacturer, failed to warn about gynecomastia to doctors and patients and awarded a young man $1million.Read [ Gynecomastia Risperdal Plaintiff Wins First Lawsuit Outside Philadelphia Court ]
October 11, 2017. By Gordon Gibb.
Syracuse, NY: One of the few Risperdal lawsuits to be tried outside Philadelphia has resulted in a win for the plaintiff, a resident of Troy in New York State who was awarded $1 million in compensation. A jury in US District Court, Northern District of New York delivered their verdict in the trial on September 27, awarding 24-year-old Shaquil Byrd $500,000 for past and/or present pain and suffering, as well as an additional $500,000 for future pain and suffering.Read [ New York State Risperdal Plaintiff Awarded $1 Million ]
September 17, 2017. By Gordon Gibb.
Philadelphia, PA: As the manufacturer of Risperdal (risperidone) continues their attempts to have a recent plaintiff verdict overturned, the Pennsylvania state judge assigned to the case explained last month why he denied a request by Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. for a new trial in the Risperdal side effects lawsuit.Read [ Risperdal Judge Explains Reasons for Denying Janssen a New Trial ]
September 11, 2017. By Gordon Gibb.
New York, NY: The plaintiff in a Risperdal lawsuit who faced a petition for summary judgement on the part of the manufacturer, won the right to pursue the majority of his claims following a ruling by a New York judge that testimony by an expert witness is admissible, and may stand.Read [ Risperdal Plaintiff Green Lighted to Pursue Risperdal Lawsuit in New York ]
August 23, 2017. By Gordon Gibb.
Philadelphia, PA: If there was ever any doubt that Risperdal gynecomastia was a compelling issue that too few knew about, that myth was dispelled when a Risperdal lawsuit landed squarely onto the pages of People Magazine in February, 2015.Read [ Philadelphia Judge Refuses to Overturn $2.5 Million Risperdal Plaintiff Verdict ]
August 9, 2017. By Jane Mundy.
New Orleans, LA: This is Frank’s story about his son Frankie, who was prescribed Risperdal to treat ADHD when he 11 years old. (Risperdal is frequently prescribed off-label for uses not approved by the FDA.) By the time Frankie was 16, he had developed “female boobs” or gynecomastia. Frank’s son was incarcerated at 18 years of age and he will be eligible for parole in three years, when he is 29 years old.Read [ Father Worries about his Incarcerated Son with Risperdal “Female Boobs” ]
July 24, 2017. By Jane Mundy.
Philadelphia, PA: In the wake of several juries ordering Johnson & Johnson to pay compensation to Risperdal victims, over 3,600 new Risperdal lawsuits have been filed since the beginning of this year. The number of lawsuits in the Philadelphia Court of Common Pleas has doubled, making the Risperdal mass-tort the largest in the system.Read [ Risperdal Now the Fastest-Growing Mass Tort Program ]
July 11, 2017. By Gordon Gibb.
Philadelphia, PA: On the day that the Philadelphia Court of Common Pleas is holding a status update and discussion on the Risperdal lawsuit file, (July 11, 2017) it’s instructive to look rearwards a year and a week to July 1, 2016 when a $70 million verdict was delivered by a Pennsylvania state court jury favoring the plaintiff in a Risperdal gynecomastia lawsuit.Read [ One Year after Blockbuster Risperdal Gynecomastia Award, Lawsuits Now Top 20,000 ]
June 25, 2017. By Gordon Gibb.
Philadelphia, PA: The Risperdal lawsuit count now stands at a number above 18,000. To that end a staggering number of cases name pharmaceutical giants Johnson & Johnson (J&J) and subsidiary Janssen Pharmaceuticals as defendants. Most allege Risperdal gynecomastia, a Risperdal side effect characterized as the growth of male breast tissue. However one Risperdal lawsuit was recently filed in Missouri alleging that Risperdal had been prescribed to children as young as two years of age.Read [ Risperdal Lawsuit Hit 18,000 and Climbing, Status Update Due in July ]